Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recall after electrical cardioversion with propofol sedation
NL-OMON23740Not yet recruiting
- Sponsor
- HMC Westeinde
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of propofol in arrhythmia, sponsored by HMC Westeinde. Primary endpoint: Incidence of painful recall of electrical cardioversion. Planned start Nov 2014; status: not yet recruiting.
02
Drugs
propofol
03
Conditions
arrhythmia
Beyond the preview
Go deeper on NL-OMON23740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23740.